Ftse Mib
33.541,98
-0,49%
DAX
18.155,24
-0,04%
S&P 500
5.477,90
0,16%
NASDAQ
17.805,16
0,49%
Bitcoin
60.857,87
0,07%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Aethlon Medical Inc (AEMD) Aethlon Medical Inc (AEMD) Notizie

Aethlon Medical Inc

AEMD
0,579
-0,0457 (-7,32%)
27 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
21/6/202414:01PRNUSAethlon Medical to Release Fiscal Year End Financial Results..
18/6/202414:01PRNUSAethlon Medical Receives Ethics Committee Approval for..
03/6/202414:01PRNUSAethlon Medical Prepares for Potentially Transformative..
24/5/202419:24EDGAR2Form 8-K - Current report
17/5/202422:05EDGAR2Form 8-K - Current report
17/5/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
16/5/202422:05EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
15/5/202415:27EDGAR2Form POS AM - Post-Effective amendments for registration..
15/5/202415:15PRNUSAethlon Medical Announces Pricing of $4.7 Million Public..
13/5/202423:30EDGAR2Form S-1/A - General form for registration of securities..
10/5/202414:01EDGAR2Form 8-K - Current report
10/5/202414:01PRNUSAethlon Medical Reports Positive Results From an In Vitro..
21/2/202414:01PRNUSAethlon Medical Enters Into Materials Transfer Agreement for..
14/2/202423:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/2/202422:15EDGAR2Form 8-K - Current report
14/2/202422:15PRNUSAethlon Medical Announces Fiscal Third Quarter Financial..
07/2/202414:00PRNUSAethlon Medical to Release Fiscal Third Quarter Financial..
03/1/202400:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202400:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202400:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202322:01EDGAR2Form 8-K/A - Current report: [Amend]
27/11/202313:49EDGAR2Form 8-K - Current report
14/11/202322:15EDGAR2Form 8-K - Current report
14/11/202322:15PRNUSAethlon Medical Announces Fiscal Second Quarter Financial..
13/11/202314:01EDGAR2Form 8-K - Current report
13/11/202314:01PRNUSAethlon Medical Announces Appointment of James B. Frakes,..
06/11/202314:01PRNUSAethlon Medical to Release Second Quarter Financial Results..
10/10/202314:01PRNUSAethlon Receives Clearance From Drug Controller General of..
04/10/202323:05EDGAR2Form 8-K - Current report
04/10/202314:01PRNUSAethlon Announces Reverse Stock Split
29/9/202323:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202323:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202323:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202315:00EDGAR2Form 8-K - Current report
30/8/202314:01PRNUSAethlon Medical to Present at the H.C. Wainwright 25th..
10/8/202323:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202322:20EDGAR2Form 8-K - Current report
10/8/202322:15PRNUSAethlon Medical Announces Fiscal First Quarter Financial..
03/8/202314:01PRNUSAethlon Medical to Release First Quarter Financial Results..
27/7/202322:18EDGAR2Form DEF 14A - Other definitive proxy statements
24/7/202314:01PRNUSAethlon Medical Signs Collaboration Agreement with 34 Lives..
17/7/202322:43EDGAR2Form PRE 14A - Other preliminary proxy statements
06/7/202323:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/7/202323:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/7/202322:15EDGAR2Form 8-K - Current report
06/7/202320:17PRNUSAethlon Medical Appoints Medical Device and Biomedical..
03/7/202322:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/7/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/6/202323:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
28/6/202322:32EDGAR2Form 8-K - Current report
Apertura: 0,62 Min: 0,55 Max: 0,6209
Chiusura: 0,6247

La tua Cronologia

NASDAQ
AEMD
Aethlon Medical
USOTC
SEEK
TheDirectory com (CE)
NASDAQ
CWC
Caribiner
TG
FEW
Funkwerk
BIT
F18169
Vontobel Financial Produ...
CSE
BATX
Battery X Metals
LSE
UC14
Ubsetf Ccusas
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network